Teleflex Incorporated, a provider of medical technologies, has entered into a new agreement with FundamentalVR, a provider of virtual reality (VR) integration for medical simulation. The agreement will provide Teleflex with a VR training platform to accelerate the effective use of the company’s UroLift 2 System, a technology for treatment of benign prostatic hyperplasia (BPH), commonly known as enlarged prostate. The VR training platform integrates tactile feedback and a digital representation of the UroLift 2 System to provide urologists with a “hands-on” VR experience that can accelerate their learning.
By leveraging the capabilities of FundamentalVR’s Fundamental Surgery platform, Teleflex aims to increase access and standardization of clinical training of the UroLift 2 System in the United States and around the world, including Japan, where the UroLift 2 System was recently approved for use. The customized solution from FundamentalVR will enable urologists globally to practice the procedure remotely in a virtual environment.
Teleflex showcased the Fundamental Surgery platform at the company’s UroLift System booth at the 2022 American Urological Association (AUA) meeting in New Orleans. The platform is officially launching and becoming available in August 2022.